Nalu
Nalu Medical developed and commercialized the Nalu Neurostimulation System, designed to deliver targeted relief for adults living with severe, intractable chronic pain of peripheral nerve origin, including areas such as the shoulder, lower back and knee, through peripheral nerve stimulation (PNS). The therapy uses mild electrical impulses to interrupt pain signals before they reach the brain. The system features a miniaturized, battery-free implantable pulse generator, powered wirelessly by a small, externally worn therapy disc and controlled via a smartphone app. The company was headquartered in Carlsbad, CA (US) and was acquired by Boston Scientific (NYSE: BSX) in 2026.